Genzyme Renagel Margin Improves As Private Contracts Grow
Executive Summary
Genzyme is seeing increased profitability in Renagel sales due to a more favorable reimbursement mix
You may also be interested in...
Genzyme Renagel (correction)
Genzyme Senior VP and Renal Division General Manager John Butler discussed Renagel sales during the company's Oct. 15 earnings call (1"The Pink Sheet" Oct. 27, 2003, p. 34). "The Pink Sheet" incorrectly attributed statements made on the call to Senior VP-Cell and Protein R&D John McPherson...
Genzyme Renagel (correction)
Genzyme Senior VP and Renal Division General Manager John Butler discussed Renagel sales during the company's Oct. 15 earnings call (1"The Pink Sheet" Oct. 27, 2003, p. 34). "The Pink Sheet" incorrectly attributed statements made on the call to Senior VP-Cell and Protein R&D John McPherson...
Genzyme Renagel Inventory Stable By 2003; Wholesaler Agreements Planned
Genzyme will use formal agreements with wholesalers to draw down excess Renagel inventory levels by the beginning of 2003, Renagel General Manager John Butler said during a conference call to announce revised earnings estimates Sept. 16